Liver cirrhosis, transplantation and organ shortage;Leberzirrhose und -transplantation: Brennpunkt organmangel

Deutsches Arzteblatt International

Volumn 110, Issue 6, 2013, Pages 83-84

  Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; NUCLEOSIDE; NUCLEOTIDE; PEGINTERFERON ALPHA;

ALCOHOLISM; EARLY DIAGNOSIS; EDITORIAL; END STAGE LIVER DISEASE; HEALTH CARE SYSTEM; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; WILSON DISEASE; COMPLICATION; GERMANY; HEPATITIS, ALCOHOLIC; HEPATITIS, VIRAL, HUMAN; TRANSPLANTATION; TRENDS;

GERMANY; HEPATITIS, ALCOHOLIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT;

EID: 84906329055     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0083     Document Type: Editorial

References (10)

1. Wiegand J, Berg T: The etiology, diagnosis and prevention of liver cirrhosis-part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013; 110(6): 85-91.
2. Poynard T, Mc Hutchison J, Manns M, et al.:Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002 122: 1303-13.
3. Schiff ER, Lee SS, Chao YC, et al.: Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol 2011; 9: 274-6.
4. Hofmann WP, Sarrazin C, Zeuzem S: Current standards in the treatment of chronic hepatitis C. Dtsch Arztebl Int 2012; 109(19): 352-84.
5. Calle Serrano B, Manns MP: HCV's days are numbered: nextgeneration direct-acting antivirals and host-targeting agents. Antivir Ther 2012; 17: 1133-46.
6. Sauerbruch T, Appenrodt B, Schmitz V, Spengler U: Conservative and interventional treatment of the complications of liver cirrhosis - part 2 of a series on liver cirrhosis. Dtsch Arztebl Int 2013; in press.
7. Pascher A, Nebrig M, Neuhaus P: Irreversible liver failure: treatment by transplantation. Dtsch Arztebl Int 2013; in press.
8. Schlitt HJ, Loss M, Scherer MN, et al.: Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Zeitschrift fur Gastroenterologie 2011; 49: 30-8.
9. Weismüller TJ, Negm A, Becker T, et al.: The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transplant International 2009; 22: 970-8.
10. DGIM: DRG-Finanzierung der Krankenhäuser und Bonussysteme für Ärzte: Im Krankenhaus Fehlentwicklungen durch falsche Anreize stoppen! Presseerklärung; www.dgim.de, 2012.